Context Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
CNTX on Nasdaq
Location
2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Context Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Evan G. Dick Former Section 16 officer $69.8K Feb 15, 2022
Tarek Sahmoud Chief Medical Officer $8.42K Aug 16, 2022
William F. Rencher Former Section 16 officer $1.4K Feb 15, 2022
Andy Pasternak Director Jan 13, 2025
Philip W. Kantoff Director Jun 13, 2024
Richard J. Berman Director Jun 13, 2024
Martin A. Lehr Chief Executive Officer, Director Feb 13, 2025
Alex Levit Chief Legal Officer, Corp. Sec Feb 13, 2025
Jennifer Lynn Minai-Azary Chief Financial Officer Feb 13, 2025
Jennifer Evans Stacey Director Jun 13, 2024
Luke Walker Director Sep 4, 2024
Linda West Director Jun 13, 2024
Karen L. Smith Director Sep 4, 2024
Ullmann Claudio Dansky Chief Medical Officer Feb 13, 2025

Recent Insider Transactions by Companies or Individuals for Context Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.